ArticleMaterials today. Bio2025
Red blood cell-activated antifreeze metal-organic framework armor for cryopreservation.
Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Inhibition of Ice Recrystallization by Regulating the Surface Free Energy of Nanoparticles.Small (Weinheim an der Bergstrasse, Germany) · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Red blood cell (RBC) cryopreservation is essential for maintaining ex vivo biological function and enabling long-term storage. However, the fragile nature of RBCs makes them highly susceptible to hemolysis during freezing and thaw cycles, limiting their widespread application. Here, a metal-organic framework (MOF)-based armor has been developed in a physiological environment, which enables one-step in situ encapsulation and unloading of RBCs. This MOF armor, functioning as a nano-bio interface, effectively shields RBCs from cryo-induced damage while preserving their native oxygen-carrying function. The MOF-armored RBCs not only inhibit ice recrystallization by restricting water molecule movement within the porous MOF structure but also serve as a "catalyst" to induce the smoothing of the ice front during growth, reducing sodium chloride eutectic formation and accelerating ice melting. Cryopreservation assays demonstrate exceptional RBC recovery (51 %) at a low MOF concentration (1 mg mL
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.